Anti- TGF-beta Receptor III Antibody

N/A

N/A

anticorps

Antibodies

Western Blot (WB)

Human (Homo sapiens)

TGF-beta Receptor III

TGF-beta Receptor III

TGF-beta Receptor III Antibody

Not applicable to Polyclonal Antibodies

BGCAN; betaglycan; TGF-beta Receptor III;

This is an antibody designed to detect TGF-beta Receptor III

Store at -20 degree C or -80 degree C. Avoid freeze / thaw cycles.

Enquire us for detailed information on the concentration of this antibody

TGFBR3; TGFBR3; BGCAN; betaglycan; TGF-beta receptor type 3; TGFR-3; TGF-beta receptor type III

If you buy Antibodies supplied by MBS Polyclonals they should be stored frozen at - 24°C for long term storage and for short term at + 5°C.

The most common purification methods used in the antibody production are Affinity Chromatography, Caprylic Acid Ammonium Sulfate Precipitation, Antigen Affinity method, etc.

transforming growth factor beta receptor type 3 isoform b; Transforming growth factor beta receptor type 3; transforming growth factor beta receptor type 3; TGFR-3; betaglycan proteoglycan; TGF-beta receptor type 3; TGF-beta receptor type III; transforming growth factor, beta receptor III; Betaglycan; Transforming growth factor beta receptor III; TGF-beta receptor type III

This antibody needs to be stored at + 4°C in a fridge short term in a concentrated dilution. Freeze thaw will destroy a percentage in every cycle and should be avoided.Antibody for research use.The receptors are ligand binding factors of type 1, 2 or 3 and protein-molecules that receive chemical-signals from outside a cell. When such chemical-signals couple or bind to a receptor, they cause some form of cellular/tissue-response, e.g. a change in the electrical-activity of a cell. In this sense, am olfactory receptor is a protein-molecule that recognizes and responds to endogenous-chemical signals, chemokinesor cytokines e.g. an acetylcholine-receptor recognizes and responds to its endogenous-ligand, acetylcholine. However, sometimes in pharmacology, the term is also used to include other proteins that are drug-targets, such as enzymes, transporters and ion-channels.